Attempts were made to prepare a sensitive antigen from C. albicans suitable for detecting humoral antibodies and hypersensitivity in deep-seated candidiasis, in patients at risk of invasive candidiasis and in allergic states caused by Candida. 5343 persons suffering from systemic, bronchial, vaginal candidiasis, bronchial asthma, chronic bronchitis, polyarthritis nodosa, ulcus cruris, malignancy, rhinitis pollinosa, vasomotorica, and non infected miners, farmers and blood donors were investigated on the presence of antibodies and hypersensitivity against 8 different antigen preparations. The extracellular protein and mannan- protein isolated from the cultivation medium of C. albicans proved the most sensitive for specific anticandida antibodies. The mannan, especially the mannan isolated from the cell surface of C. albicans determined best for the allergy. Comparison made of commerical Candidine showed similar activity. The whole cell C. albicans antigens as well as the mixed Candida antigen reacted much weakly. Comparison made of autoantigen, C. albicans and mixed C. albicans antigen proved the highest sensitivity of the autoantigen.

Download full-text PDF

Source
http://dx.doi.org/10.1007/BF00440616DOI Listing

Publication Analysis

Top Keywords

antibodies hypersensitivity
8
albicans
6
immunodiagnosis candida-infections
4
candida-infections sensitivity
4
sensitivity antigens
4
antigens attempts
4
attempts prepare
4
prepare sensitive
4
antigen
4
sensitive antigen
4

Similar Publications

The purpose of this study was to evaluate dermatologists' knowledge, attitudes, and practices (KAP) concerning omalizumab therapy for chronic urticaria. We conducted a cross-sectional study in several hospitals in China, mainly in hospitals in Zhejiang Province, during August 1, 2024 - August 15, 2024 using a self-administered KAP questionnaire. Wilcoxon-Mann-Whitney tests and Kruskal-Wallis analysis of variance were performed to compare differences across groups Factors influencing practice were determined through multivariable logistic regression.

View Article and Find Full Text PDF

Coexistence of Asymptomatic Allergic Bronchopulmonary Aspergillosis and Active Pulmonary Tuberculosis: Case Report.

Infect Drug Resist

January 2025

Department of Pulmonary and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, 610041, People's Republic of China.

We present a rare case of asymptomatic allergic bronchopulmonary aspergillosis (ABPA) concurrent with active pulmonary tuberculosis. Allergic bronchopulmonary aspergillosis is an immunological pulmonary disorder characterized by hypersensitivity to Aspergillus fumigatus, while pulmonary tuberculosis (PTB) is a complex infection caused by Mycobacterium tuberculosis (MTB). The association between pulmonary tuberculosis infections and Aspergillus infections remains a fascinating area of inquiry.

View Article and Find Full Text PDF

Background: This study aimed to investigate the possible association of LPCAT1-rs8352 genetic variant (single nucleotide change C to G) with the onset and severity of pediatric asthma. Additionally, the study examined the influence of LPCAT1-rs8352 genotypes on asthma-related biomarkers including blood eosinophils count (BEC), eosinophil cationic protein (ECP), high-sensitivity C-reactive protein (hs-CRP), and immunoglobulin E (IgE) and on lung function [forced expiratory volume in one second (FEV1) and the forced vital capacity (FVC)].

Patients And Methods: The study included ninety-six participant grouped into two groups: G1 (46 asthmatics) and G2 (50 healthy controls).

View Article and Find Full Text PDF

Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis.

J Dermatolog Treat

December 2025

Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

Purpose: Dupilumab is a widely recommended treatment for moderate-to-severe atopic dermatitis (AD), with known ocular side effects but less frequent cutaneous reactions.

Material And Methods: This case report details a 52-year-old female patient with atopic dermatitis treated with dupilumab. After an initially successful treatment, the patient developed a rosacea-like dermatitis.

View Article and Find Full Text PDF

Preclinical and clinical studies have established that autoreactive immunoglobulin G (IgG) can drive neuropathic pain. We recently demonstrated that sciatic nerve chronic constriction injury (CCI) in male and female mice results in the production of pronociceptive IgG, which accumulates around the lumbar region, including within the dorsal root ganglia (DRG) and spinal cord, facilitating the development of neuropathic pain. These data raise the intriguing possibility that neuropathic pain may be alleviated by reducing the accumulation of IgG.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!